Form D · Biotechnology

Janus Biotherapeutics, Inc.

Wellesley, MA · CIK 0001514481

Offering snapshot reported Aug 20, 2020 · SEC filing

Reported sold
$668K
Offering amount: $4M
Investors reported
8
Form D · investor count
Minimum accepted
$0
Reported outside-investor minimum
First sale
Jul 16, 2020
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Aug 20, 2020Initial$668,228No comparison8SEC filing
Aug 19, 2011Initial$1,100,000No comparison6SEC filing
Mar 16, 2011Initial$500,000No comparison1SEC filing

Offering details

Securities
Equity
Exemptions
06b
Duration over one year
No
Business combination
No
Sales commissions
$0
Finders' fees
$0
Form D file number
021-373655

Source: Form D, filed Aug 20, 2020. Minimum accepted may differ from a standard advertised minimum.

Fund connections

The linked fund shows its most recently reported ADV details.

Matched by reported Form D file number

K2 HEDGE FUND TRACKER LLC

Investment adviser: K2/D&S MANAGEMENT CO., L.L.C.

Gross asset value
$5.3M
Beneficial owners
2
ADV minimum commitment
$0

Reported in Form ADV on May 16, 2019. Fund assets and beneficial owners measure different things from Form D sales and investors.

Service providers

Fund administrator HEDGESERV LIMITED DUBLIN, Ireland Investor statements: Yes (provided to all investors) Related to adviser: No
Auditor ERNST & YOUNG STAMFORD, Connecticut, United States
Custodian THE BANK OF NEW YORK MELLON NEW YORK, New York, United States Related to adviser: No
Prime broker MORGAN STANLEY & CO. LLC NEW YORK, New York, United States
Provider details
Annual audit
Yes
Prime brokers
Yes
Custodians
Yes
Administrator other than the adviser
Yes
External marketing
No

ERNST & YOUNG
PCAOB 42

MORGAN STANLEY & CO. LLC
CRD 8209 · SEC 8-15869

Filing source

Form ADV 1323748 · May 16, 2019 · Schedule D 7.B.(1), fund 805-9201981418

Official IAPD profile (latest public filing). Values are the most recently reported in our imported data; the public profile may show a newer filing.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Joseph Baron Director, Executive
Steven Bernitz Director
Christine De Los Reyes Director
Grayson Lipford Director, Executive
Jonathan Reis Director

Issuer details

Industry: Biotechnology (See others in industry)

Address:
65 William Street Suite 200
Wellesley, MA, 02481